Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study
Identifieur interne : 000595 ( Istex/Corpus ); précédent : 000594; suivant : 000596Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study
Auteurs : S. Vignes ; A. DupuySource :
- Journal of the European Academy of Dermatology and Venereology [ 0926-9959 ] ; 2006-08.
Abstract
Objective To identify the predictors of successful antibiotic prophylactic treatment using benzathin‐penicillin G to prevent recurrence of erysipelas in patients with secondary upper limb lymphoedema.
Url:
DOI: 10.1111/j.1468-3083.2006.01648.x
Links to Exploration step
ISTEX:0CB5C97B81677BB8EF3DBAC629DF280532150674Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study</title><author><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name><affiliation><mods:affiliation>Department of Lymphology, Hôpital Cognacq‐Jay, and</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: stephane.vignes@hopital‐cognacq‐jay.fr</mods:affiliation></affiliation></author><author><name sortKey="Dupuy, A" sort="Dupuy, A" uniqKey="Dupuy A" first="A" last="Dupuy">A. Dupuy</name><affiliation><mods:affiliation>Department of Dermatology, Hôpital Saint Louis, Paris, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0CB5C97B81677BB8EF3DBAC629DF280532150674</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1111/j.1468-3083.2006.01648.x</idno><idno type="url">https://api.istex.fr/document/0CB5C97B81677BB8EF3DBAC629DF280532150674/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000595</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000595</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study</title><author><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name><affiliation><mods:affiliation>Department of Lymphology, Hôpital Cognacq‐Jay, and</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: stephane.vignes@hopital‐cognacq‐jay.fr</mods:affiliation></affiliation></author><author><name sortKey="Dupuy, A" sort="Dupuy, A" uniqKey="Dupuy A" first="A" last="Dupuy">A. Dupuy</name><affiliation><mods:affiliation>Department of Dermatology, Hôpital Saint Louis, Paris, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of the European Academy of Dermatology and Venereology</title><title level="j" type="alt">JOURNAL OF EUROPEAN ACADEMY DERMATOLOGY VENEREOLOGY</title><idno type="ISSN">0926-9959</idno><idno type="eISSN">1468-3083</idno><imprint><biblScope unit="vol">20</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="818">818</biblScope><biblScope unit="page" to="822">822</biblScope><biblScope unit="page-count">5</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2006-08">2006-08</date></imprint><idno type="ISSN">0926-9959</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0926-9959</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Objective To identify the predictors of successful antibiotic prophylactic treatment using benzathin‐penicillin G to prevent recurrence of erysipelas in patients with secondary upper limb lymphoedema.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>lymphoedema</json:string><json:string>prophylactic</json:string><json:string>erysipelas</json:string><json:string>prophylaxis</json:string><json:string>recurrence</json:string><json:string>penicillin</json:string><json:string>antibiotic</json:string><json:string>erysipelas recurrence</json:string><json:string>antibiotic prophylactic treatment</json:string><json:string>lymphology</json:string><json:string>breast cancer</json:string><json:string>recurrent erysipelas</json:string><json:string>upper limb lymphoedema</json:string><json:string>predictor</json:string><json:string>cohort</json:string><json:string>prophylactic penicillin therapy</json:string><json:string>median</json:string><json:string>breast cancer treatment</json:string><json:string>european academy</json:string><json:string>lymphoedema volume</json:string><json:string>penicillin therapy</json:string><json:string>prophylactic treatment</json:string><json:string>antibiotic prophylaxis</json:string><json:string>manual lymphatic drainage</json:string><json:string>body mass index</json:string><json:string>international society</json:string><json:string>excess volume</json:string><json:string>erysipelas recurrences</json:string><json:string>past erysipelas</json:string><json:string>hormone therapy</json:string><json:string>recurrence rate</json:string><json:string>previous studies</json:string><json:string>prophylactic antibiotherapy</json:string></teeft></keywords><author><json:item><name>S Vignes</name><affiliations><json:string>Department of Lymphology, Hôpital Cognacq‐Jay, and</json:string><json:string>E-mail: stephane.vignes@hopital‐cognacq‐jay.fr</json:string></affiliations></json:item><json:item><name>A Dupuy</name><affiliations><json:string>Department of Dermatology, Hôpital Saint Louis, Paris, France</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>breast cancer</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>lymphoedema</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>risk factor</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>secondary</value></json:item></subject><articleId><json:string>JDV1648</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><qualityIndicators><score>3.129</score><pdfVersion>1.3</pdfVersion><pdfPageSize>595 x 782 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>201</abstractCharCount><pdfWordCount>2841</pdfWordCount><pdfCharCount>19010</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>24</abstractWordCount></qualityIndicators><title>Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study</title><genre><json:string>article</json:string></genre><host><title>Journal of the European Academy of Dermatology and Venereology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1468-3083</json:string></doi><issn><json:string>0926-9959</json:string></issn><eissn><json:string>1468-3083</json:string></eissn><publisherId><json:string>JDV</json:string></publisherId><volume>20</volume><issue>7</issue><pages><first>818</first><last>822</last><total>5</total></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>dermatology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>dermatology & venereal diseases</json:string></scienceMetrix></categories><publicationDate>2006</publicationDate><copyrightDate>2006</copyrightDate><doi><json:string>10.1111/j.1468-3083.2006.01648.x</json:string></doi><id>0CB5C97B81677BB8EF3DBAC629DF280532150674</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/0CB5C97B81677BB8EF3DBAC629DF280532150674/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/0CB5C97B81677BB8EF3DBAC629DF280532150674/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/0CB5C97B81677BB8EF3DBAC629DF280532150674/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study</title></titleStmt><publicationStmt><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2006-08"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study</title><title level="a" type="short">Recurrence of erysipelas under prophylactic antibiotherapy</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">S</forename><surname>Vignes</surname></persName><affiliation>Department of Lymphology, Hôpital Cognacq‐Jay, and</affiliation><affiliation>*Corresponding author, Department of Lymphology, Hôpital Cognacq‐Jay, Site Broussais, 102 rue Didot, 75014 Paris, France, tel. +33 1 56 56 42 57; fax +33 1 56 56 42 58; E‐mail: stephane.vignes@hopital‐cognacq‐jay.fr</affiliation></author><author xml:id="author-0001"><persName><forename type="first">A</forename><surname>Dupuy</surname></persName><affiliation>Department of Dermatology, Hôpital Saint Louis, Paris, France<address><country key="FR"></country></address></affiliation></author><idno type="istex">0CB5C97B81677BB8EF3DBAC629DF280532150674</idno><idno type="DOI">10.1111/j.1468-3083.2006.01648.x</idno><idno type="unit">JDV1648</idno><idno type="toTypesetVersion">file:JDV.JDV1648.pdf</idno></analytic><monogr><title level="j" type="main">Journal of the European Academy of Dermatology and Venereology</title><title level="j" type="alt">JOURNAL OF EUROPEAN ACADEMY DERMATOLOGY VENEREOLOGY</title><idno type="pISSN">0926-9959</idno><idno type="eISSN">1468-3083</idno><idno type="book-DOI">10.1111/(ISSN)1468-3083</idno><idno type="book-part-DOI">10.1111/jdv.2006.20.issue-7</idno><idno type="product">JDV</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">20</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="818">818</biblScope><biblScope unit="page" to="822">822</biblScope><biblScope unit="page-count">5</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2006-08"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract xml:lang="en" style="main"><head>Summary</head><p><hi rend="bold">Objective </hi> To identify the predictors of successful antibiotic prophylactic treatment using benzathin‐penicillin G to prevent recurrence of erysipelas in patients with secondary upper limb lymphoedema.</p><p><hi rend="bold">Design </hi> A retrospective cohort study.</p><p><hi rend="bold">Setting and patients </hi> Patients with secondary arm lymphoedema were recruited in a single lymphology unit between 1990 and 2003. All patients had had at least three recurrences of erysipelas. Patients were given 2.4 MU benzathin‐penicillin G intramuscularly at 14‐day intervals. For each patient, the following data were recorded: characteristics of breast cancer treatment (type of surgery, radiotherapy, hormone therapy), number of erysipelas recurrences before inclusion, patient characteristics including body mass index (BMI) and lymphoedema volume at inclusion.</p><p><hi rend="bold">Main outcome measures </hi> The outcome studied was the occurrence of erysipelas on the affected arm under antibiotic prophylactic treatment.</p><p><hi rend="bold">Results </hi> With a 4.2‐year median follow‐up from the onset of antibiotic prophylactic treatment, 23 of 48 women experienced recurrence of erysipelas. The median duration of erysipelas recurrence‐free period under this treatment was 2.7 years. The estimated rate of recurrence was 26%[95% confidence interval (CI) 13–38%] at 1 year and 36% (95% CI 22–50%) at 2 years. No patient stopped the treatment because of side‐effects. No predictive factor of erysipelas recurrence under antibiotic prophylactic treatment was identified.</p><p><hi rend="bold">Conclusions </hi> Antibiotic prophylaxis using benzathin‐penicillin is a well‐tolerated treatment of erysipelas recurrence in patients with upper limb lymphoedema secondary to breast cancer. The rate of erysipelas recurrence was 26% at 1 year in patients who had a history of at least one erysipelas. We did not find any predictor of erysipelas recurrence.</p></abstract><textClass><keywords xml:lang="en"><term xml:id="k1">breast cancer</term><term xml:id="k2">lymphoedema</term><term xml:id="k3">risk factor</term><term xml:id="k4">secondary </term></keywords><classCode scheme="tocHeading1">ORIGINAL ARTICLES</classCode></textClass><langUsage><language ident="EN"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/0CB5C97B81677BB8EF3DBAC629DF280532150674/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1468-3083</doi><issn type="print">0926-9959</issn><issn type="electronic">1468-3083</issn><idGroup><id type="product" value="JDV"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="JOURNAL OF EUROPEAN ACADEMY DERMATOLOGY VENEREOLOGY">Journal of the European Academy of Dermatology and Venereology</title></titleGroup></publicationMeta><publicationMeta level="part" position="08007"><doi origin="wiley">10.1111/jdv.2006.20.issue-7</doi><numberingGroup><numbering type="journalVolume" number="20">20</numbering><numbering type="journalIssue" number="7">7</numbering></numberingGroup><coverDate startDate="2006-08">August 2006</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="10" status="forIssue"><doi origin="wiley">10.1111/j.1468-3083.2006.01648.x</doi><idGroup><id type="unit" value="JDV1648"></id></idGroup><countGroup><count type="pageTotal" number="5"></count></countGroup><titleGroup><title type="tocHeading1">ORIGINAL ARTICLES</title></titleGroup><eventGroup><event type="firstOnline" date="2006-06-06"></event><event type="publishedOnlineFinalForm" date="2006-06-06"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.4 mode:FullText source:FullText result:FullText" date="2010-03-30"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-19"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-30"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="818">818</numbering><numbering type="pageLast" number="822">822</numbering></numberingGroup><correspondenceTo>
*Corresponding author, Department of Lymphology, Hôpital Cognacq‐Jay, Site Broussais, 102 rue Didot, 75014 Paris, France, tel. +33 1 56 56 42 57; fax +33 1 56 56 42 58; E‐mail: <email normalForm="stephane.vignes@hopital-cognacq-jay.fr">stephane.vignes@hopital‐cognacq‐jay.fr</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:JDV.JDV1648.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Received: 30 March 2005, accepted 28 June 2005; DOI: 10.1111/j.1468‐3083.2006.01648.x</unparsedEditorialHistory><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="1"></count><count type="formulaTotal" number="0"></count><count type="referenceTotal" number="23"></count><count type="wordTotal" number="2971"></count></countGroup><titleGroup><title type="main">Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study</title><title type="shortAuthors">Vignes and Dupuy</title><title type="short">Recurrence of erysipelas under prophylactic antibiotherapy</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>S</givenNames><familyName>Vignes</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a2"><personName><givenNames>A</givenNames><familyName>Dupuy</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1"><unparsedAffiliation>Department of Lymphology, Hôpital Cognacq‐Jay, and</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="FR"><unparsedAffiliation>Department of Dermatology, Hôpital Saint Louis, Paris, France</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">breast cancer</keyword><keyword xml:id="k2">lymphoedema</keyword><keyword xml:id="k3">risk factor</keyword><keyword xml:id="k4">secondary </keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Summary</title><p><b>Objective </b> To identify the predictors of successful antibiotic prophylactic treatment using benzathin‐penicillin G to prevent recurrence of erysipelas in patients with secondary upper limb lymphoedema.</p><p><b>Design </b> A retrospective cohort study.</p><p><b>Setting and patients </b> Patients with secondary arm lymphoedema were recruited in a single lymphology unit between 1990 and 2003. All patients had had at least three recurrences of erysipelas. Patients were given 2.4 MU benzathin‐penicillin G intramuscularly at 14‐day intervals. For each patient, the following data were recorded: characteristics of breast cancer treatment (type of surgery, radiotherapy, hormone therapy), number of erysipelas recurrences before inclusion, patient characteristics including body mass index (BMI) and lymphoedema volume at inclusion.</p><p><b>Main outcome measures </b> The outcome studied was the occurrence of erysipelas on the affected arm under antibiotic prophylactic treatment.</p><p><b>Results </b> With a 4.2‐year median follow‐up from the onset of antibiotic prophylactic treatment, 23 of 48 women experienced recurrence of erysipelas. The median duration of erysipelas recurrence‐free period under this treatment was 2.7 years. The estimated rate of recurrence was 26%[95% confidence interval (CI) 13–38%] at 1 year and 36% (95% CI 22–50%) at 2 years. No patient stopped the treatment because of side‐effects. No predictive factor of erysipelas recurrence under antibiotic prophylactic treatment was identified.</p><p><b>Conclusions </b> Antibiotic prophylaxis using benzathin‐penicillin is a well‐tolerated treatment of erysipelas recurrence in patients with upper limb lymphoedema secondary to breast cancer. The rate of erysipelas recurrence was 26% at 1 year in patients who had a history of at least one erysipelas. We did not find any predictor of erysipelas recurrence.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Recurrence of erysipelas under prophylactic antibiotherapy</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Vignes</namePart><affiliation>Department of Lymphology, Hôpital Cognacq‐Jay, and</affiliation><affiliation>E-mail: stephane.vignes@hopital‐cognacq‐jay.fr</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Dupuy</namePart><affiliation>Department of Dermatology, Hôpital Saint Louis, Paris, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2006-08</dateIssued><edition>Received: 30 March 2005, accepted 28 June 2005; DOI: 10.1111/j.1468‐3083.2006.01648.x</edition><copyrightDate encoding="w3cdtf">2006</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="tables">1</extent><extent unit="references">23</extent><extent unit="words">2971</extent></physicalDescription><abstract>Objective To identify the predictors of successful antibiotic prophylactic treatment using benzathin‐penicillin G to prevent recurrence of erysipelas in patients with secondary upper limb lymphoedema.</abstract><abstract>Design A retrospective cohort study.</abstract><abstract>Setting and patients Patients with secondary arm lymphoedema were recruited in a single lymphology unit between 1990 and 2003. All patients had had at least three recurrences of erysipelas. Patients were given 2.4 MU benzathin‐penicillin G intramuscularly at 14‐day intervals. For each patient, the following data were recorded: characteristics of breast cancer treatment (type of surgery, radiotherapy, hormone therapy), number of erysipelas recurrences before inclusion, patient characteristics including body mass index (BMI) and lymphoedema volume at inclusion.</abstract><abstract>Main outcome measures The outcome studied was the occurrence of erysipelas on the affected arm under antibiotic prophylactic treatment.</abstract><abstract>Results With a 4.2‐year median follow‐up from the onset of antibiotic prophylactic treatment, 23 of 48 women experienced recurrence of erysipelas. The median duration of erysipelas recurrence‐free period under this treatment was 2.7 years. The estimated rate of recurrence was 26%[95% confidence interval (CI) 13–38%] at 1 year and 36% (95% CI 22–50%) at 2 years. No patient stopped the treatment because of side‐effects. No predictive factor of erysipelas recurrence under antibiotic prophylactic treatment was identified.</abstract><abstract>Conclusions Antibiotic prophylaxis using benzathin‐penicillin is a well‐tolerated treatment of erysipelas recurrence in patients with upper limb lymphoedema secondary to breast cancer. The rate of erysipelas recurrence was 26% at 1 year in patients who had a history of at least one erysipelas. We did not find any predictor of erysipelas recurrence.</abstract><subject lang="en"><genre>keywords</genre><topic>breast cancer</topic><topic>lymphoedema</topic><topic>risk factor</topic><topic>secondary</topic></subject><relatedItem type="host"><titleInfo><title>Journal of the European Academy of Dermatology and Venereology</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0926-9959</identifier><identifier type="eISSN">1468-3083</identifier><identifier type="DOI">10.1111/(ISSN)1468-3083</identifier><identifier type="PublisherID">JDV</identifier><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>818</start><end>822</end><total>5</total></extent></part></relatedItem><identifier type="istex">0CB5C97B81677BB8EF3DBAC629DF280532150674</identifier><identifier type="DOI">10.1111/j.1468-3083.2006.01648.x</identifier><identifier type="ArticleID">JDV1648</identifier><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000595 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000595 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:0CB5C97B81677BB8EF3DBAC629DF280532150674
|texte= Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study
}}
| This area was generated with Dilib version V0.6.31. |  |